The WHO recognizes human African trypanosomiasis, Chagas disease and the
leishmaniases as neglected tropical diseases. These diseases are caused by parasitic …

Progress in the diagnosis of leishmaniases depends on the development of effective
methods and the discovery of suitable biomarkers. We propose firstly an update …

Infections with protozoan parasites are a major cause of disease and mortality in many
tropical countries of the world. Diseases caused by species of the genera Trypanosoma …

Leishmaniasis is one of the most neglected tropical disease in terms of drug discovery and
development. Most antileishmanial drugs are highly toxic, present resistance issues or …

Mathematical models are powerful tools to study various real-world problems from different
perspectives. This branch has been given much more popularity over the last several …

Leishmaniasis remains a major public health problem worldwide and is classified as
Category I by the TDR/WHO, mainly due to the absence of control. Many experimental …

Leishmaniasis is one of the world's most neglected diseases, largely affecting the poorest of
the poor, mainly in developing countries. Over 350 million people are considered at risk of …

Visceral leishmaniasis is a neglected tropical disease with significant health impact. The
current treatments are poor, and there is an urgent need to develop new drugs. Primary …

Oceans cover seventy percent of the planet's surface and besides being an immense
reservoir of biological life, they serve as vital sources for human sustenance, tourism …

Although there have been significant advances in the treatment of visceral leishmaniasis
(VL) and several novel compounds are currently in pre-clinical and clinical development for …